Form 8-K - Current report:
SEC Accession No. 0001193125-24-234814
Filing Date
2024-10-09
Accepted
2024-10-09 08:40:04
Documents
47
Period of Report
2024-10-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d882180d8k.htm   iXBRL 8-K 26596
2 EX-99.1 d882180dex991.htm EX-99.1 43037
6 GRAPHIC g882180ex99_1p10g1.jpg GRAPHIC 324283
7 GRAPHIC g882180ex99_1p11g1.jpg GRAPHIC 254034
8 GRAPHIC g882180ex99_1p12g1.jpg GRAPHIC 431808
9 GRAPHIC g882180ex99_1p13g1.jpg GRAPHIC 509805
10 GRAPHIC g882180ex99_1p14g1.jpg GRAPHIC 249491
11 GRAPHIC g882180ex99_1p15g1.jpg GRAPHIC 319899
12 GRAPHIC g882180ex99_1p16g1.jpg GRAPHIC 214836
13 GRAPHIC g882180ex99_1p17g1.jpg GRAPHIC 311085
14 GRAPHIC g882180ex99_1p18g1.jpg GRAPHIC 229926
15 GRAPHIC g882180ex99_1p19g1.jpg GRAPHIC 269690
16 GRAPHIC g882180ex99_1p1g1.jpg GRAPHIC 331977
17 GRAPHIC g882180ex99_1p20g1.jpg GRAPHIC 347740
18 GRAPHIC g882180ex99_1p21g1.jpg GRAPHIC 309359
19 GRAPHIC g882180ex99_1p22g1.jpg GRAPHIC 237906
20 GRAPHIC g882180ex99_1p23g1.jpg GRAPHIC 376000
21 GRAPHIC g882180ex99_1p24g1.jpg GRAPHIC 431496
22 GRAPHIC g882180ex99_1p25g1.jpg GRAPHIC 453073
23 GRAPHIC g882180ex99_1p26g1.jpg GRAPHIC 325999
24 GRAPHIC g882180ex99_1p27g1.jpg GRAPHIC 250138
25 GRAPHIC g882180ex99_1p28g1.jpg GRAPHIC 209324
26 GRAPHIC g882180ex99_1p29g1.jpg GRAPHIC 379571
27 GRAPHIC g882180ex99_1p2g1.jpg GRAPHIC 512018
28 GRAPHIC g882180ex99_1p30g1.jpg GRAPHIC 466917
29 GRAPHIC g882180ex99_1p31g1.jpg GRAPHIC 263760
30 GRAPHIC g882180ex99_1p32g1.jpg GRAPHIC 353659
31 GRAPHIC g882180ex99_1p33g1.jpg GRAPHIC 252774
32 GRAPHIC g882180ex99_1p3g1.jpg GRAPHIC 380713
33 GRAPHIC g882180ex99_1p4g1.jpg GRAPHIC 338643
34 GRAPHIC g882180ex99_1p5g1.jpg GRAPHIC 357634
35 GRAPHIC g882180ex99_1p6g1.jpg GRAPHIC 276575
36 GRAPHIC g882180ex99_1p7g1.jpg GRAPHIC 264435
37 GRAPHIC g882180ex99_1p8g1.jpg GRAPHIC 257240
38 GRAPHIC g882180ex99_1p9g1.jpg GRAPHIC 357969
  Complete submission text file 0001193125-24-234814.txt   15161103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikt-20241009.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20241009_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20241009_pre.xml EX-101.PRE 11712
49 EXTRACTED XBRL INSTANCE DOCUMENT d882180d8k_htm.xml XML 3768
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 241361580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)